Sort by
Refine Your Search
-
the supervision of Dr. Joseph Kwon. We’re seeking a creative Postdoctoral Scholar to join our team and advance cutting-edge multiscale and hybrid modeling—integrating first-principles simulations with
-
multiperspectival environment. Mershon postdocs receive mentoring as a cohort, along with assistance from our affiliates in building individual networks across campus. They are expected to devote approximately 10
-
therapeutic approaches. Many of our studies use human and murine models and employ a wide range of techniques to interrogate systems ranging from intact fresh tissue to individual cells. The Postdoctoral
-
, immunology, molecular biology, proteomics, animal modeling and mouse genetics, translational medicine, and/or the use of human tumor models of solid tumors (e.g. breast cancer, colon cancer, neuroblastoma
-
quality of life for adults with hearing loss. This position is ideal for candidates with interests in auditory cognition, aging and hearing, linguistic processing, or CI rehabilitation. The postdoc will
-
under the guidance of his/her scientific mentor to investigate the interoception neuron circuit using the zebrafish model; independently designs new analytical approaches and tools; performs experiments
-
. The research involves the development of practical and computationally efficient methods for adapting and fitting models from survival analysis to infectious disease transmission data and other data, including
-
| Civil Environmental and Geodetic Engineering We invite applications for an exciting opportunity for a postdoctoral research associate position in the domain of digital twin modeling for infrastructures
-
immunology to join our NIH-funded research group to study the role of host cellular proteins in pulmonary inflammation and respiratory virus pathogenesis. Experience in virology, immunology and mouse model
-
the behavioral side effects of cancer chemotherapy that are associated with inflammation. We will use mouse modeling to study mechanisms and run a pilot clinical trial in women with breast cancer. We